TY - JOUR
T1 - A clinical approach to diagnosis of autoimmune encephalitis
AU - Graus, Francesc
AU - Titulaer, Maarten J.
AU - Balu, Ramani
AU - Benseler, Susanne
AU - Bien, Christian G.
AU - Cellucci, Tania
AU - Cortese, Irene
AU - Dale, Russell C.
AU - Gelfand, Jeffrey M.
AU - Geschwind, Michael
AU - Glaser, Carol A.
AU - Honnorat, Jerome
AU - Höftberger, Romana
AU - Iizuka, Takahiro
AU - Irani, Sarosh R.
AU - Lancaster, Eric
AU - Leypoldt, Frank
AU - Prüss, Harald
AU - Rae-Grant, Alexander
AU - Reindl, Markus
AU - Rosenfeld, Myrna R.
AU - Rostásy, Kevin
AU - Saiz, Albert
AU - Venkatesan, Arun
AU - Vincent, Angela
AU - Wandinger, Klaus Peter
AU - Waters, Patrick
AU - Dalmau, Joseph
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a complex differential diagnosis. Advances in autoimmune encephalitis research in the past 10 years have led to the identification of new syndromes and biomarkers that have transformed the diagnostic approach to these disorders. However, existing criteria for autoimmune encephalitis are too reliant on antibody testing and response to immunotherapy, which might delay the diagnosis. We reviewed the literature and gathered the experience of a team of experts with the aims of developing a practical, syndrome-based diagnostic approach to autoimmune encephalitis and providing guidelines to navigate through the differential diagnosis. Because autoantibody test results and response to therapy are not available at disease onset, we based the initial diagnostic approach on neurological assessment and conventional tests that are accessible to most clinicians. Through logical differential diagnosis, levels of evidence for autoimmune encephalitis (possible, probable, or definite) are achieved, which can lead to prompt immunotherapy.
AB - Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a complex differential diagnosis. Advances in autoimmune encephalitis research in the past 10 years have led to the identification of new syndromes and biomarkers that have transformed the diagnostic approach to these disorders. However, existing criteria for autoimmune encephalitis are too reliant on antibody testing and response to immunotherapy, which might delay the diagnosis. We reviewed the literature and gathered the experience of a team of experts with the aims of developing a practical, syndrome-based diagnostic approach to autoimmune encephalitis and providing guidelines to navigate through the differential diagnosis. Because autoantibody test results and response to therapy are not available at disease onset, we based the initial diagnostic approach on neurological assessment and conventional tests that are accessible to most clinicians. Through logical differential diagnosis, levels of evidence for autoimmune encephalitis (possible, probable, or definite) are achieved, which can lead to prompt immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=84960486545&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(15)00401-9
DO - 10.1016/S1474-4422(15)00401-9
M3 - Scientific review articles
C2 - 26906964
AN - SCOPUS:84960486545
SN - 1474-4422
VL - 15
SP - 391
EP - 404
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 4
ER -